Finance

Lists
Why is ALA down 4,08%?
Dive Deeper
ALA:ASX
Arovella Therapeutics Ltd
0,047 A$
-4,08%
(-0,0020) 1D
20 қар., 12:05:47 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ALA...
Open
0,05 A$
High
0,05 A$
Low
0,05 A$
Mkt. cap
56,82 млн
Avg. vol.
638,74 м.
Volume
495,18 м.
52-wk high
0,10 A$
52-wk low
0,05 A$
EPS
-0,01 A$
Shares outstanding
1,21 млрд
No. of employees
14
Open
0,05 A$
High
0,05 A$
Low
0,05 A$
Mkt. cap
56,82 млн
Avg. vol.
638,74 м.
Volume
495,18 м.
52-wk high
0,10 A$
52-wk low
0,05 A$
EPS
-0,01 A$
Shares outstanding
1,21 млрд
No. of employees
14
News stories
From web sources and news partners
Adam Feldman | Substack
Adam Feldman | Substack
·
7 сағат бұрын
Inside the Federal Litigation of Five S&P 500 Giants
The Harvard Law School Forum on Corporate Governance
The Harvard Law School Forum on Corporate Governance
·
13 сағат бұрын
Board Practices and Composition in the Russell 3000 and S&P 500
RealMoney Pro
RealMoney Pro
·
3 сағат бұрын
Anthropic Pops, but the S&P 500 Drops
About Arovella Therapeutics Ltd
CEOMichael Baker
Employees14
Founded1999
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,60 млн
1,60 млн
144,61 м.
144,61 м.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,37 млн
1,37 млн
1,57 млн
1,57 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
721,91 м.
721,91 м.
670,81 м.
670,81 м.
Operating expense
2,75 млн
2,75 млн
2,86 млн
2,86 млн
Total operating expenses
2,75 млн
2,75 млн
2,86 млн
2,86 млн
Operating income
-1,15 млн
-1,15 млн
-2,71 млн
-2,71 млн
Other non operating income
-
-
-
-
EBT including unusual items
-939,35 м.
-939,35 м.
-2,52 млн
-2,52 млн
EBT excluding unusual items
-939,35 м.
-939,35 м.
-2,52 млн
-2,52 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
449,58 м.
449,58 м.
528,34 м.
528,34 м.
Net income
-939,35 м.
-939,35 м.
-2,52 млн
-2,52 млн
Net profit margin
-58,55%
-58,55%
-1 741,81%
-1 741,81%
Earnings per share
-
-
-
-
Interest and investment income
207,81 м.
207,81 м.
192,21 м.
192,21 м.
Interest expense
-
-
-
-
Net interest expenses
207,81 м.
207,81 м.
192,21 м.
192,21 м.
Depreciation and amortization charges
29,58 мың
29,58 мың
29,28 мың
29,28 мың
EBITDA
-1,12 млн
-1,12 млн
-2,68 млн
-2,68 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары